Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 30, 2013 - Issue 7
Submit an article Journal homepage
493
Views
20
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLESolid Tumors

Inflammatory Myofibroblastic Tumors in Childhood

Bhakti MehtaDivision of Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, California, USA
, MD, MPH,
Leo Mascarenhas
, MD, MS,
Shengmei ZhouDepartment of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California, USA
, MD,
Larry WangDepartment of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California, USA
, MD, PhD &
Rajkumar VenkatramaniCorrespondence[email protected]
, MD, MS
Pages 640-645 | Received 11 Jun 2013, Accepted 14 Jun 2013, Published online: 29 Aug 2013

REFERENCES

  • Coffin CM, Hornick JL, Fletcher CDM. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31(4):509–520.
  • Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol. 1995;19(8):859–872.
  • Gleason BC, Hornick JL. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol. 2008;61(4):428–437.
  • Alaggio R, Cecchetto G, Bisogno G, Inflammatory myofibroblastic tumors in childhood: a report from the Italian Cooperative Group studies. Cancer. 2010;116(1):216–226.
  • Borak S, Siegal GP, Reddy V, Metastatic inflammatory myofibroblastic tumor identified by EUS-FNA in mediastinal lymph nodes with ancillary FISH studies for ALK rearrangement. Diagno Cytopathol. 2012;40(Suppl 2):E118–E125.
  • Diop B, Konate I, Ka S, Mesenteric myofibroblastic tumor: NSAID therapy after incomplete resection. J. Visceral Surg. 2011;148(4):e311–e314.
  • Carillo C, Anile M, De Giacomo T, Venuta F. Bilateral simultaneous inflammatory myofibroblastic tumor of the lung with distant metastatic spread. Interact Cardiovasc Thorac Surg. 2011;13(2):246–247.
  • Ernst CW, Van Der Werff Ten Bosch J, Desprechins B, Malignant transformation of an abdominal inflammatory myofibroblastic tumor with distant metastases in a child. JBR-BTR. 2011;94(2):78–80.
  • Song Z, Zhang Y, Xu X, Inflammatory myofibroblastic tumor invading pulmonary trunk with multiple mediastinal lymph node metastasis. Ann Thorac Surg. 2011;92(1):e15.
  • Dishop MK, Warner BW, Dehner LP, Successful treatment of inflammatory myofibroblastic tumor with malignant transformation by surgical resection and chemotherapy. J Pediatr Hematol Oncol. 2003;25(2):153–158.
  • Su W, Ko A, O'Connell TX, Applebaum H. Treatment of pseudotumors with nonsteroidal antiinflammatory drugs. J Pediatr Surg. 2000;35(11):1635–1637.
  • Favini F, Resti AG, Collini P, Inflammatory myofibroblastic tumor of the conjunctiva: response to chemotherapy with low-dose methotrexate and vinorelbine. Pediatr Blood Cancer. 2010;54(3):483–485.
  • Mergan F, Jaubert F, Sauvat F, Inflammatory myofibroblastic tumor in children: clinical review with anaplastic lymphoma kinase, Epstein-Barr virus, and human herpesvirus 8 detection analysis. J Pediatr Surg. 2005;40(10):1581–1586.
  • Arber DA, Kamel OW, van de Rijn M, Frequent presence of the Epstein-Barr virus in inflammatory pseudotumor. Hum Pathol. 1995;26(10):1093–1098.
  • Kasaragod AB, Lucia MS, Cabirac G, et al. Connective tissue growth factor expression in pediatric myofibroblastic tumors. Pediatr Dev Pathol. 2001;4(1):37–45.
  • Giuriato S, Faumont N, Bousquet E, Development of a conditional bioluminescent transplant model for TPM3-ALK-induced tumorigenesis as a tool to validate ALK-dependent cancer targeted therapy. Cancer Biol Ther. 2007;6(8):1318–1323.
  • Lamant L, Dastugue N, Pulford K, A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation. Blood. 1999;93(9):3088–3095.
  • Butrynski JE, D'Adamo DR, Hornick JL, Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med. 2010;363(18):1727–1733.
  • Mossé YP, Lim MS, Voss SD, Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a children's oncology group phase 1 consortium study. Lancet Oncol. 2013;14(6):472–480.
  • Mariño-Enríquez A, Wang W-L, Roy A, Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Am J Surg Pathol. 2011;35(1):135–144.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.